INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 174 filers reported holding INOVIO PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.29 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $87,922 | -64.4% | 226,021 | -59.2% | 0.00% | -66.7% |
| Q2 2023 | $247,131 | +222540.5% | 553,484 | +310.5% | 0.00% | +50.0% |
| Q1 2023 | $111 | -48.8% | 134,820 | -3.3% | 0.00% | -50.0% |
| Q4 2022 | $217 | -99.9% | 139,397 | -29.1% | 0.00% | -55.6% |
| Q2 2022 | $340,000 | +89.9% | 196,533 | +295.2% | 0.01% | +125.0% |
| Q1 2022 | $179,000 | -88.9% | 49,734 | -84.6% | 0.00% | -85.2% |
| Q4 2021 | $1,617,000 | -17.5% | 323,968 | +18.3% | 0.03% | -15.6% |
| Q3 2021 | $1,961,000 | +112.2% | 273,854 | +174.6% | 0.03% | +88.2% |
| Q2 2021 | $924,000 | +293.2% | 99,721 | +391.2% | 0.02% | +70.0% |
| Q3 2020 | $235,000 | -50.7% | 20,301 | +14.8% | 0.01% | -58.3% |
| Q2 2020 | $477,000 | +182.2% | 17,690 | -22.1% | 0.02% | +60.0% |
| Q1 2020 | $169,000 | -46.7% | 22,712 | -54.6% | 0.02% | +87.5% |
| Q3 2017 | $317,000 | +27.8% | 50,000 | +86.6% | 0.01% | +60.0% |
| Q2 2016 | $248,000 | -43.4% | 26,801 | -46.7% | 0.01% | -54.5% |
| Q1 2016 | $438,000 | +403.4% | 50,305 | +232.8% | 0.01% | +266.7% |
| Q3 2015 | $87,000 | -27.5% | 15,116 | +23.7% | 0.00% | -25.0% |
| Q3 2014 | $120,000 | – | 12,215 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Affinity Asset Advisors, LLC | 200,000 | $998,000 | 0.36% |
| Green Alpha Advisors, LLC | 72,647 | $363,000 | 0.24% |
| Skaana Management L.P. | 227,851 | $1,137,000 | 0.18% |
| SEVEN EIGHT CAPITAL, LP | 196,351 | $980,000 | 0.18% |
| Defender Capital, LLC. | 103,038 | $514,000 | 0.16% |
| Skaana Management L.P. | 206,300 | $1,029,000 | 0.16% |
| WASATCH ADVISORS LP | 4,926,125 | $24,581,000 | 0.10% |
| Parametrica Management Ltd | 16,183 | $81,000 | 0.08% |
| Cedar Brook Financial Partners, LLC | 54,500 | $272,000 | 0.07% |
| Hennion & Walsh Asset Management, Inc. | 274,703 | $1,371,000 | 0.07% |